This study explored the short-term effects of vitamin K2 (VK2) supplementation on biochemical parameters (vitamin D, vitamin E, vitamin A, alkaline phosphatase, calcium, phosphorus (P), magnesium, metallothionein, triglycerides, cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and lipoprotein fractions (albumin, HDL, very low-density lipoprotein (VLDL), LDL, and chylomicrons). A short-term experiment (24 h, six probands) was performed to track changes in VK2 levels after a single-dose intake (360 µg/day). Liquid chromatography-tandem mass spectrometry was used to monitor vitamin K levels (menaquinone-4 (MK-4), menaquinone-7 (MK-7), and vitamin K1 [VK1]) with a limit of detection of 1.9 pg/mL for VK1 and 3.8 pg/mL for the two forms of VK2. Results showed that MK-7 levels significantly increased within 2-6 h post-administration and then gradually declined. MK-4 levels were initially low, showing a slight increase, whereas VK1 levels rose initially and then decreased. Biochemical analyses indicated no significant changes in sodium, chloride, potassium, calcium, magnesium, albumin, or total protein levels. A transient increase in P was observed, peaking at 12 h before returning to baseline. Agarose gel electrophoresis of lipoprotein fractions revealed distinct chylomicron bands and variations in VLDL and HDL mobility, influenced by dietary lipids and VK2 supplementation. These findings suggest effective absorption and metabolism of MK-7 with potential implications for bone metabolism and cardiovascular health.

1st Department of Orthopaedics 1st Faculty of Medicine Charles University Prague Motol University Hospital Prague Czechia

Council for Nutritional and Environmental Medicine Mo i Rana Norway

Department of Medical Chemistry and Clinical Biochemistry 2nd Faculty of Medicine Charles University Prague Motol University Hospital Prague Czechia

See more in PubMed

Kostina D, Lobov A, Klausen P, Karelkin V, Tikhilov R, Bozhkova S, et al. Isolation of human osteoblast cells capable for mineralization and synthetizing bone‐related proteins in vitro from adult bone. Cells. 2022;11(21):3356.

Nair P, Orford N, Kerschan‐Schindl K. Micronutrient intake to protect against osteoporosis during and after critical illness. Cur Opin Clin Nutr Metabol Care. 2023;26(6):557–563.

Fusaro M, Barbuto S, Gallieni M, Cossettini A, Sartò GVR, Cosmai L, et al. Real‐world usage of chronic kidney disease–mineral bone disorder (CKD–MBD) biomarkers in nephrology practices. Clin Kidney J. 2024;17(1):sfad290.

Bose S, Sarkar N, Banerjee D. Natural medicine delivery from biomedical devices to treat bone disorders: a review. Acta Biomater. 2021;126:63–91.

Valentino A, Di Cristo F, Bosetti M, Amaghnouje A, Bousta D, Conte R, et al. Bioactivity and delivery strategies of phytochemical compounds in bone tissue regeneration. Appl Sci. 2021;11(11):5122.

Camelo‐Castillo A, Rivera‐Caravaca JM, Orenes‐Pinero E, Ramirez‐Macias I, Roldan V, Lip GYH, et al. Gut microbiota and the quality of oral anticoagulation in vitamin K antagonists users: a review of potential implications. J Clin Med. 2021;10(4):715.

Fusaro M, Plebani M, Tripepi G, Iervasi G, Cunningham J, Locatelli F, et al. Vitamin K2 is a key regulator of clinically relevant molecular processes. In: Molecular nutrition: vitamins. Cambridge: Academic Press; 2020. p. 153–172.

Fusaro M, Gallieni M, Rizzo MA, Stucchi A, Delanaye P, Cavalier E, et al. Vitamin K plasma levels determination in human health. Clin Chem Lab Med. 2017;55(6):789–799.

Yan QX, Zhang T, O'Connor C, Barlow JW, Walsh J, Scalabrino G, et al. The biological responses of vitamin K2: a comprehensive review. Food Sci Nutr. 2023;11(4):1634–1656.

Beulens JWJ, Booth SL, van den Heuvel E, Stoecklin E, Baka A, Vermeer C. The role of menaquinones (vitamin K2) in human health. Brit J Nutr. 2013;110(8):1357–1368.

Kujawska A, Bromage S, Simoes JA, Zupkauskiene J, McMahon N, Zalewski P, et al. The impact of dietary supplements on blood pressure in older adults: a network meta‐analysis of randomized controlled trials. Heliyon. 2024;10(4):e25615.

Gasmi A, Bjørklund G, Peana M, Mujawdiya PK, Pivina L, Ongenae A, et al. Phosphocalcic metabolism and the role of vitamin D, vitamin K2, and nattokinase supplementation. Crit Rev Food Sci Nutr. 2022;62(25):7062–7071.

Hegele RA. Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet. 2009;10(2):109–121.

Sultana H, Komai M, Shirakawa H. The role of vitamin K in cholestatic liver disease. Nutrients. 2021;13(8):2515.

Shandilya S, Kesari KK, Ruokolainen J. Vitamin K2 modulates organelle damage and tauopathy induced by streptozotocin and menadione in SH‐SY5Y cells. Antioxidants. 2021;10(6):983.

Grzejszczak P, Kurnatowska I. Role of vitamin K in CKD: is its supplementation advisable in CKD patients? Kid Blood Pres Res. 2021;46(5):523–530.

Janssen R, Visser MPJ, Dofferhoff ASM, Vermeer C, Janssens W, Walk J. Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in Coronavirus disease 2019. Brit J Nutr. 2021;126(2):191–198.

Boraldi F, Annovi G, Vermeer C, Schurgers LJ, Trenti T, Tiozzo R, et al. Matrix gla protein and alkaline phosphatase are differently modulated in human dermal fibroblasts from PXE patients and controls. J Invest Dermatol. 2013;133(4):946–954.

Barna M, Cepová J, Dunovská K, Petrus J, Melichercík P, Prusa R, et al. Chemiluminescent and photometric analysis of matrix gla protein from patients with a defect of musculoskeletal system. Chem Listy. 2023;117(11):694–700.

Zhao QY, Li Q, Rashedi MH, Sohouli M, Rohani P, Velu P. The effect of vitamin K supplementation on cardiovascular risk factors: a systematic review and meta‐analysis. J Nutr Sci. 2024;13:e3.

Booth SL. Vitamin K: food composition and dietary intakes. Food Nutr Res. 2012;56. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321250/

Plaza SM, Lamson DW. Vitamin K2 in bone metabolism and osteoporosis. Alter Med Rev. 2005;10(1):24–35.

Barna M, Cepova J, Dunovska K, Melichercík P, Prusa R, Kizek R, et al. Biochemical significance of matrix gla protein and its potential use as a marker in clinical biochemistry. Chem Listy. 2024;118(5):270–276.

Eelderink C, Kremer D, Riphagen IJ, Knobbe TJ, Schurgers LJ, Pasch A, et al. Effect of vitamin K supplementation on serum calcification propensity and arterial stiffness in vitamin K‐deficient kidney transplant recipients: a double‐blind, randomized, placebo‐controlled clinical trial. Am J Transplant. 2023;23(4):520–530.

Bellone F, Cinquegrani M, Nicotera R, Carullo N, Casarella A, Presta P, et al. Role of vitamin K in chronic kidney disease: a focus on bone and cardiovascular health. Int J Mol Sci. 2022;23(9):5282.

Mandatori D, Pelusi L, Schiavone V, Pipino C, Di Pietro N, Pandolfi A. The dual role of vitamin K2 in “bone‐vascular crosstalk”: opposite effects on bone loss and vascular calcification. Nutrients. 2021;13(4):1222.

Sardiwal S, Magnusson P, Goldsmith DJA, Lamb EJ. Bone alkaline phosphatase in CKD‐mineral bone disorder. Am J Kid Dis. 2013;62(4):810–822.

Niemeier A, Niedzielska D, Secer R, Schilling A, Merkel M, Enrich C, et al. Uptake of postprandial lipoproteins into bone in vivo: impact on osteoblast function. Bone. 2008;43(2):230–237.

Zhang B, Li L, Zeng H, Xu X, Wang R, Chen M, et al. Association between bone turnover markers and the risk of imminent recurrent osteoporotic fracture. Med Int. 2022;2(4):1–7.

Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol. 2009;20(7):1453–1464.

Schumacher MM, Elsabrouty R, Seemann J, Jo Y, DeBose‐Boyd RA. The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase. eLife. 2015;4:e05560.

Vimalraj S. Alkaline phosphatase: structure, expression and its function in bone mineralization. Gene. 2020;754:144855.

Sogabe N, Maruyama R, Hosoi T, Goseki‐Sone M. Enhancement effects of vitamin K‐1 (phylloquinone) or vitamin K‐2 (menaquinone‐4) on intestinal alkaline phosphatase activity in rats. J Nutr Sci Vitamin. 2007;53(3):219–224.

Orimo H. The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med School. 2010;77(1):4–12.

Coburn SP, Mahuren JD, Jain M, Zubovic Y, Wortsman J. Alkaline phosphatase (EC 3.1.3.1) in serum is inhibited by physiological concentrations of inorganic phosphate. J Clin Endocrinol Metab. 1998;83(11):3951–3957.

Haarhaus M, Brandenburg V, Kalantar‐Zadeh K, Stenvinkel P, Magnusson P. Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD. Nat Rev Nephrol. 2017;13(7):429–442.

Noda S, Yamada A, Tanabe R, Nakaoka K, Hosoi T, Goseki‐Sone M. Menaquinone‐4 (vitamin K‐2) up‐regulates expression of human intestinal alkaline phosphatase in Caco‐2 cells. Nutr Res. 2016;36(11):1269–1276.

Li H, Zhang JK, Liu SN, Yan YF, Li XM. Consecutive dephosphorylation by alkaline phosphatase‐directed in situ formation of porous hydrogels of SF with nanocrystalline calcium phosphate ceramics for bone regeneration. J Mater Chem B. 2020;8(39):9043–9051.

Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, et al. Tissue‐nonspecific alkaline phosphatase and plasma cell membrane glycoprotein‐1 are central antagonistic regulators of bone mineralization. Proc Nat Acad Sci USA. 2002;99(14):9445–9449.

Lukacs JL, Reame NE. Concentrations of follicle‐stimulating hormone correlate with alkaline phosphatase and a marker for vitamin K status in the perimenopause. J Womens Health Gend Based Med. 2000;9(7):731–739.

Domínguez‐Rodríguez G, Montero L, Herrero M, Cifuentes A, Castro‐Puyana M. Capillary electromigration methods for food analysis and foodomics: advances and applications in the period March 2021 to March 2023. Electrophoresis. 2024;45(1–2):8–34.

Klejdus B, Petrlova J, Potesil D, Adam V, Mikelova R, Vacek J, et al. Simultaneous determination of water‐ and fat‐soluble vitamins in pharmaceutical preparations by high‐performance liquid chromatography coupled with diode array detection. Anal Chim Acta. 2004;520(1–2):57–67.

Mrstna K, Matousova K, Krcmova LK, Carazo A, Pourova J, Mladenka P, et al. Analysis of vitamin K1 and major K2 variants in rat/human serum and lipoprotein fractions by a rapid, simple, and sensitive UHPLC–MS/MS method. J Chrom A. 2024;1714:464548.

Sebia instructions. Hydragel. Sebia instructions: France. 2020.

Petrlova J, Potesil D, Mikelova R, Blastik O, Adam V, Trnkova L, et al. Attomole voltammetric determination of metallothionein. Electrochim Acta. 2006;51(24):5112–5119.

Hubaux A, Vos G. Decision and detection limits for calibration curves. J Anal Chem. 1970;42(8):849–855.

Bernal J, Mendiola JA, Ibáñez E, Cifuentes A. Advanced analysis of nutraceuticals. J Pharm Biomed Anal. 2011;55(4):758–774.

Dunovska K, Klapkova E, Sopko B, Cepova J, Prusa R. LC‐MS/MS quantitative analysis of phylloquinone, menaquinone‐4 and menaquinone‐7 in the human serum of a healthy population. PeerJ. 2019;7:e7699.

Food and Drug Administration (FDA). Bioanalytical method validation guidance for industry [FDA‐2013‐D‐1020]. In: Center for drug evaluation and research center for veterinary medicine. Maryland: FDA; 2018. p. 1–41.

Gau JT, Ebersbacher C, Kao TC. Serum zinc concentrations of adults in an outpatient clinic and risk factors associated with zinc deficiency. J Am Osteopath Assoc. 2020;120(11):796–805.

Kuo TR, Chen CH. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomarker Res. 2017;5:18.

Krzyzanowska‐Jankowska P, Nowak J, Karazniewicz‐Lada M, Jamka M, Klapkova E, Kurek S, et al. Vitamin K status based on K1, MK‐4, MK‐7, and undercarboxylated prothrombin levels in adolescent and adult patients with cystic fibrosis: a cross‐sectional study. Nutrients. 2024;16(9):1337.

Sakak FR, Moslehi N, Niroomand M, Mirmiran P. Glycemic control improvement in individuals with type 2 diabetes with vitamin K2 supplementation: a randomized controlled trial. Eur J Nutr. 2021;60(5):2495–2506.

Laouali N, MacDonald CJ, Shah S, El Fatouhi D, Mancini FR, Fagherazzi G, et al. Dietary copper/zinc ratio and type 2 diabetes risk in women: the E3N cohort study. Nutrients. 2021;13(8):2502.

Li S, Kim M‐J, Lee S‐H, Jin L, Cong W, Jeong H‐G, et al. Metallothionein 3 promotes osteoblast differentiation in C2C12 cells via reduction of oxidative stress. Int J Mol Sci. 2021;22(9):4312.

Wang C, Gong Z, Hu S, Zhang G. Metallothionein‐1 is associated with osteoarthritis disease activity and suppresses proinflammatory cytokines production in synovial cells. Int Immunopharmacol. 2019;75:105815.

Fong L, Tan K, Tran C, Cool J, Scherer MA, Elovaris R, et al. Interaction of dietary zinc and intracellular binding protein metallothionein in postnatal bone growth. Bone. 2009;44(6):1151–1162.

Akbulut AC, Wasilewski GB, Rapp N, Forin F, Singer H, Czogalla‐Nitsche KJ, et al. Menaquinone‐7 supplementation improves osteogenesis in pluripotent stem cell derived mesenchymal stem cells. Front Cell Dev Biol. 2021;8:618760.

Knapen MHJ, Braam L, Teunissen KJ, van't Hoofd CM, Zwijsen RML, van den Heuvel E, et al. Steady‐state vitamin K2 (menaquinone‐7) plasma concentrations after intake of dairy products and soft gel capsules. Eur J Clin Nutr. 2016;70(7):831–836.

Hwang SB, Choi MJ, Lee HJ, Han JJ. Safety evaluation of vitamin K2 (menaquinone‐7) via toxicological tests. Sci Rep. 2024;14(1):5440.

Moller M, Gjelstad IMF, Baksaas I, Grande T, Aukrust IR, Drevon CA. Bioavailability and chemical/functional aspects of synthetic MK‐7 vs fermentation‐derived MK‐7 in randomised controlled trials. Int J Vitam Nutr Res. 2016;87(5–6):297–311.

Sato T, Schurgers LJ, Uenishi K. Comparison of menaquinone‐4 and menaquinone‐7 bioavailability in healthy women. Nutr J. 2012;11:93.

van Summeren MJH, Braam L, Lilien MR, Schurgers LJ, Kuis W, Vermeer C. The effect of menaquinone‐7 (vitamin K2) supplementation on osteocalcin carboxylation in healthy prepubertal children. Brit J Nutr. 2009;102(8):1171–1178.

Ikeda S, Hanzawa F, Takahashi S, Suzuki N, Sano K, Oda H, et al. Tissue distribution of menaquinone‐7 and the effect of alpha‐tocopherol intake on menaquinone‐7 concentration in rats. J Nutr Sci Vitaminol. 2018;64(6):391–398.

Weisell J, Ruotsalainen AK, Näpänkangas J, Jauhiainen M, Rysä J. Menaquinone 4 increases plasma lipid levels in hypercholesterolemic mice. Sci Rep. 2021;11(1):3014.

Greenspan P, Mao FW, Ryu BH, Gutman RL. Advances in agarose gel electrophoresis of serum lipoproteins. J Chromatogr A. 1995;698(1–2):333–339.

Wada M, Mise J. An investigation of serum lipoprotein disc electrophoresis and identification of the resolved lipoprotein. Jpn Circ J. 1972;36:335–347.

Sakurai T, Sakurai A, Vaisman BL, Amar MJ, Liu CY, Gordon SM, et al. Creation of apolipoprotein C‐II (ApoC‐II) mutant mice and correction of their hypertriglyceridemia with an ApoC‐II mimetic peptides. J Pharmacol Exp Ther. 2016;356(2):341–353.

Xu N, Dahlback B, Ohlin AK, Nilsson A. Association of vitamin K‐dependent coagulation proteins and C4b binding protein with triglyceride‐rich lipoproteins of human plasma. Arterioscler Thromb Vasc Biol. 1998;18(1):33–39.

Chiva A. Agarose gel electrophoresis of joint fluid using Hyrys‐Hydrasys SEBIA system as a new prognostic tool for periprosthetic osteolysisin revision arthroplasty. J Med Life. 2013;6(3):249.

Lougheed M, Lum CM, Ling WH, Suzuki H, Kodama T, Steinbrecher U. High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II. J Biol Chem. 1997;272(20):12938–12944.

Schurgers LJ, Vermeer C. Differential lipoprotein transport pathways of K‐vitamins in healthy subjects. Biochim Biophys Acta. 2002;1570(1):27–32.

Tan J, Li Y. Revisiting the interconnection between lipids and vitamin K metabolism: insights from recent research and potential therapeutic implications: a review. Nutr Metab. 2024;21(1):1–8.

Kelly JM, Ordovas JM, Matuszek G, Smith CE, Huggins GS, Dashti HS, et al. The contribution of lipids to the interindividual response of vitamin K biomarkers to vitamin K supplementation. Mol Nutr Food Res. 2019;63(24):e1900399.